Scott Ward Biography and Net Worth

Director of InspireMD

Mr. Ward has over 40 years of experience in the healthcare industry, including nearly 30 years at Medtronic, Inc. where he served in various leadership roles including as Senior Vice President and President of the CardioVascular, Neurological and Diabetes businesses. Mr. Ward is the Founder of Raymond Holdings, a firm with activities in venture capital, strategy and transactional advisory services for medical technology and life science companies. He earned his Bachelor of Science in Genetics and Cell Biology, his Master of Science in Toxicology, and his Master of Business Administration, all from the University of Minnesota.

What is Scott R. Ward's net worth?: The estimated net worth of Scott R. Ward is at least $168.34 thousand as of May 7th, 2026. Mr. Ward owns 237,096 shares of InspireMD stock worth more than $168,338 as of September 28th. This net worth estimate does not reflect any other assets that Mr. Ward may own. Learn More about Scott R. Ward's net worth.
How do I contact Scott R. Ward?: The corporate mailing address for Mr. Ward and other InspireMD executives is 6303 Waterford District Drive, Suite 215, Miami, FL, 33126. InspireMD can also be reached via phone at 9728887766804 and via email at [email protected]. Learn More on Scott R. Ward's contact information.
Has Scott R. Ward been buying or selling shares of InspireMD?: Scott R. Ward has not been actively trading shares of InspireMD in the last ninety days. Most recently, on Thursday, May 7th, Scott R. Ward bought 73,255 shares of InspireMD stock. The stock was acquired at an average cost of $1.15 per share, with a total value of $84,243.25. Following the completion of the transaction, the director now directly owns 237,096 shares of the company's stock, valued at $272,660.40. Learn More on Scott R. Ward's trading history.
Are insiders buying or selling shares of InspireMD?: In the last year, InspireMD insiders bought shares 9 times. They purchased a total of 303,771 shares worth more than $348,697.40. In the last year, insiders at the sold shares 12 times. They sold a total of 86,913 shares worth more than $126,870.28. The most recent insider tranaction occured on May, 27th when Director Paul Stuka bought 20,000 shares worth more than $17,600.00. Insiders at InspireMD own 25.0% of the company. Learn More about insider trades at InspireMD.
Information on this page was last updated on 5/27/2026.

Scott R. Ward Insider Trading History at InspireMD

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction	Details
5/7/2026	Buy	73,255	$1.15	$84,243.25	237,096
5/6/2026	Buy	15,995	$1.15	$18,394.25	163,841

Scott R. Ward Buying and Selling Activity at InspireMD

InspireMD Company Overview

InspireMD, Inc., a medical device company, focuses on the development and commercialization of MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia Pacific. The company offers CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Stent System, a mesh-covered self-expanding carotid stent; and SwitchGuard NPS, a non-invasive transcarotid artery revascularization device; as well as treating acute stroke with tandem lesions. InspireMD, Inc. has a strategic agreement with Jacobs Institute to execute an early feasibility study of CGuard Prime for the treatment of acute stroke patients with tandem lesions. The company sells its products through local distribution partners. InspireMD, Inc. was founded in 2005 and is headquartered in Tel Aviv-Yafo, Israel.

Today's Range

Now: $0.69

$0.68

$0.71

50 Day Range

MA: $0.79

$0.65

$0.98

2 Week Range

Now: $0.69

$0.63

$2.57

Volume

10,100 shs

Average Volume

141,170 shs

Market Capitalization

$32.12 million

P/E Ratio

N/A

Dividend Yield